SLGL

NASDAQ open

Sol-Gel Technologies

54.50 USD
▲+0.42+0.78%
盘后 64.99 0.00%
2026-11-20
市值
$180.76M
市盈率
—
EPS
-5.26
股息率
—
52 周区间
32.51 – 97.97
成交量
17.30K
Beta
1.24
目标价
155.50
52W 低 32.5152W 高 97.97
价格走势

公司简介

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-...